LAPAROSCOPIC RADICAL NEPHRECTOMY


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. Evaluation of retrospective results of treatment of patients with kidney cancer, who have undergone a laparoscopic or a retroperitoneoscopic radical nephrectomy. Materials and Methods. We have conducted a retrospective analysis of 185 patients with kidney tumour, who have undergone a laparoscopic or a retroperitoneoscopic radical nephrectomy during 2010-2015. Amongst the participants there were 116 men (62.7%) and 69 women (37.3%) aged 29-86 (average age of 58.1 years). 150 patients (81.1%) have performed radical nephrectomy by transperitoneal access, while 30 patients (16.2%) experienced identical process through retroperitoneal access. 5 cases (2.7%) hybrid technique was utilized. 97 patients performed nephrectomy on the right side, 88 patients on the left side. 178 patients (96.2%) had a single kidney tumours, while 7 (3.8%) had multiple tumours ranging between 2-8. 15 patients, who experienced a laparoscopic radical nephrectomy, had a thrombus in kidney vein (level 1 under Mayo classification). 1 patient had a thrombus in vena cava (level 2). Results. Only one of the patients suffered a fatal outcome. 12 patients (6.5%) had a conversion. The duration of operation ranged between 50-215 minutes (average of 104.3 minutes), time of insufflation ranged between 36-205 minutes (average of 96.2 minutes). Average intraoperative blood loss constituted 147.8 ml. Patients spent 2-18 days (average 4.1 days) in the hospital after the surgery. Conclusion. There is an obvious advantage to utilizing a laparoscopic or a retroperitoneoscopic intervention in order to treat kidney cancer. The process constitutes minimal invasiveness, low death rates, minimal intraoperative blood loss and fast rehabilitation of the patients. 72% of patients who have who have experienced surgical intervention, such as radical nephrectomy, spent only 3-4 days in the hospital.

全文:

受限制的访问

作者简介

R. Naghiyev

Email: rauf_naghiyev@mail.ru
Department of Urology, Azerbaijan Medical University PhD, Teaching Assistant Baku, Azerbaijan

S. Imamverdiyev

Department of Urology, Azerbaijan Medical University Baku, Azerbaijan

O. Sanly

Department of Urology, Azerbaijan Medical University Baku, Azerbaijan

参考

  1. Ljungberg B., Bensalah K., Bex A.et al. EAU Guidelines on Renal Cell Carsinoma. 2014. 1-48 р.
  2. Lopatkin N.A. Urology: national handbook / Ed. Lopatkin N.A. M.: GEOTAR-Media, 2009. 801-817 p. Russian (Лопаткин Н.А. Урология: национальное руководство / Под ред. Н.А. Ло паткина. М.: ГЭОТАР-Медиа, 2009. 801-817 с.).
  3. Lipworth L., Tarone RE., McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006;176:2353-2358.
  4. Pischon T., Lahmann P.H., Boeing H., Tj0nneland A., Halkjaer J., Overvad K., Klipstein-Grobusch K., Linseisen J., Becker N., Trichopoulou A., Benetou V., Trichopoulos D., Sieri S., Palli D., Tumino R., Vineis P., Panico S., Monninkhof E., Peeters P.H., Bueno-de-Mesquita H.B., Büchner F.L., Ljungberg B., Hallmans G., Berglund G., Gonzalez C.A., Dorronsoro M., Gurrea A.B., Navarro C., Martinez C., Quiros J.R., Roddam A., Allen N., Bingham S., Khaw K.T., Kaaks R., Norat T., Slimani N., Riboli E. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006;118(3):728-738.
  5. Weikert S., Boeing H., Pischon T., Weikert C., Olsen A., Tjonneland A., Overvad K., Becker N., Linseisen J., Trichopoulou A., Mountokalakis T., Trichopoulos D., Sieri S., Palli D., Vineis P., Panico S., Peeters P.H., Bueno-de-Mesquita H.B., Verschuren W.M., Ljungberg B., Hallmans G., Berglund G., Gonzalez C.A., Dorronsoro M., Barricarte A., Tormo M.J., Allen N., Roddam A., Bingham S., Khaw K.T., Rinaldi S., Ferrari P., Norat T., Riboli E. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167(4):438-446.
  6. Popov S.V., Novikov A.I., Skryabin O.N., Zaitsev E.V. Endovideosurgical treatment of patients with kidney tumors. S.: SPbMAPO, 2011. 30 p. Russian (Попов С.В., Новиков А.И., Скрябин О.Н., Зайцев Э.В. Эндовидеохирургическое лечение больных с опухолями почек. С.: СПбМАПО, 2011. 30 с.).
  7. Clayman R.V., Kavoussi L.R., Soper N.J. et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991;146(2):278-282.
  8. Steinberg A.P., Finelli A., Desai M.M., Abreu S.C., Ramani A.P., Spaliviero M., Rybicki L., Kaouk J., Novick A.C., Gill I.S. Laparoscopic radical nephrectomy for large (greater than 7 cm, T2) renal tumors. J Urol. 2004;172:2172-2176.
  9. Park Y.H., Lee E.S., Kim H.H., Kwak C., Ku J.H., Lee S.E., Byun S.S., Hong S.K., Kim Y.J., Kang S.H., Hong S.H. Long-term oncologic outcomes of hand-assisted laparoscopic radical nephrectomy for clinically localized renal cell carcinoma: a multi-institutional comparative study. J Laparoendosc Adv Surg Tech A. 2014;24(8):556-562.
  10. Laird A., Choy K.C., Delaney H., Cutress M.L., O'Connor K.M., Tolley D.A., McNeill S.A., Stewart G.D., Riddick A.C. Matched pair analysis of laparoscopic versus open radical nephrectomy for the treatment of T3 renal cell carcinoma. World J Urol. 2015; 33(1):25-32.
  11. Siani L.M., Ferranti F., Benedetti M., De Carlo A., Quintiliani A. Laparoscopic versus open radical nephrectomy in T1-T2 renal carcinoma: personal 5-year experience about the oncologic outcome. Minerva Chir. 2011; 66(4):317-321.
  12. Gratzke C., Seitz M., Bayrle F., Schlenker B., Bastian P.J., Haseke N., Bader M., Tilki D., Roosen A., Karl A., Reich O., Khoder W.Y., Wyler S., Stief C.G., Staehler M., Bachmann A. Quality of life and perioperative outcomes after retroperitoneoscopic radical nephrectomy (RN), open RN and nephron-sparing surgery in patients with renal cell carcinoma. BJU Int. 2009;104(4):470-475.
  13. Ono Y., Kinukawa T., Hattori R., Gotoh M., Kamihira O., Ohshima S. The long-term outcome of laparoscopic radical nephrectomy for small renal cell carcinoma. J Urol. 2001;165:1867-1870.
  14. Portis A.J., Yan Y., Landman J., Chen C., Barrett P.H., Fentie D.D., Ono Y., McDougall E.M., Clayman R.V. Long-term followup after laparoscopic radical nephrectomy. J Urol. 2002;167:1257-1262.
  15. Laird A., Choy K.C., Delaney H., Cutress M.L., O'Connor K.M., Tolley D.A., McNeill S.A., Stewart G.D., Riddick A.C. Matched pair analysis of laparoscopic versus open radical nephrectomy for the treatment of T3 renal cell carcinoma. World J Urol. 2015; 33(1):25-32.
  16. Alvarez-Maestro M., Rios E., Martínez-Piñeiro L., Diez J., Sánchez F.J., Linares A. Limits of laparoscopic radical nephrectomy. Arch Esp Urol. 2013;66(1):168-179.
  17. Kirkali Z., Van Poppel H. Analysis of surgery for kidney cancer with vena cava invasion. Eur Urol. 2007; 52: 658-662.
  18. Novara G., Ficarra V., Antonelli A., Artibani W., Bertini R., Carini M., Cosciani Cunico S., Imbimbo C., Longo N., Martignoni G., Martorana G., Minervini A., Mirone V., Montorsi F., Schiavina R., Simeone C., Serni S., Simonato A., Siracusano S., Volpe A., Carmignani G. SATURN Project-LUNA Foundation. Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol. 2010;58(4):588-595.
  19. Kato M., Suzuki T., Suzuki Y., Terasawa Y., Sasano H., Arai Y. Natural history of small renal cell carcinoma: evolution of growth rate, histological grade, cell proliferation and apoptosis. J Urol. 2004;172(3):863-866.
  20. Patard J.J., Leray E., Rodriguez A., Rioux-Leclercq N., Guillé F., Lobel B. Correlation between symptom graduation, tumor characteristics and survival in renal cell carcinoma. Eur Urol. 2003;44(2):226-232.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2016
##common.cookie##